RYAN ARTHUR F sold 0.6% of their position (100.00 shares) of REGENERON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $78.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−7.00
Price / share
$777.46
Trade value
$5.44K
% of position
Common Stock
Shares
−2.00
Price / share
$778.30
Trade value
$1.56K
% of position
Common Stock
Shares
−5.00
Price / share
$779.69
Trade value
$3.90K
% of position
Common Stock
Shares
−3.00
Price / share
$780.69
Trade value
$2.34K
% of position
Common Stock
Shares
−2.00
Price / share
$781.21
Trade value
$1.56K
% of position
Common Stock
Shares
−2.00
Price / share
$782.62
Trade value
$1.57K
% of position
Common Stock
Shares
−10.00
Price / share
$783.62
Trade value
$7.84K
% of position
Common Stock
Shares
−9.00
Price / share
$784.48
Trade value
$7.06K
% of position
Common Stock
Shares
−11.00
Price / share
$785.48
Trade value
$8.64K
% of position
Common Stock
Shares
−7.00
Price / share
$786.61
Trade value
$5.51K
% of position
Common Stock
Shares
−2.00
Price / share
$787.34
Trade value
$1.57K
% of position
Common Stock
Shares
−20.00
Price / share
$788.96
Trade value
$15.78K
% of position
Common Stock
Shares
−20.00
Price / share
$789.28
Trade value
$15.79K
% of position
Net shares
−100.00
Net value
-$78.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | S · Sale | −7.00 | $777.46 | $5.44K | 0.0% | 17.80K | 17.80K |
| Common Stock Direct | 3/2/2026 | S · Sale | −2.00 | $778.30 | $1.56K | 0.0% | 17.80K | 17.79K |
| Common Stock Direct | 3/2/2026 | S · Sale | −5.00 | $779.69 | $3.90K | 0.0% | 17.79K | 17.79K |
| Common Stock Direct | 3/2/2026 | S · Sale | −3.00 | $780.69 | $2.34K | 0.0% | 17.79K | 17.79K |
| Common Stock Direct | 3/2/2026 | S · Sale | −2.00 | $781.21 | $1.56K | 0.0% | 17.79K | 17.78K |
| Common Stock Direct | 3/2/2026 | S · Sale | −2.00 | $782.62 | $1.57K | 0.0% | 17.78K | 17.78K |
| Common Stock Direct | 3/2/2026 | S · Sale | −10.00 | $783.62 | $7.84K | 0.1% | 17.78K | 17.77K |
| Common Stock Direct | 3/2/2026 | S · Sale | −9.00 | $784.48 | $7.06K | 0.1% | 17.77K | 17.76K |
| Common Stock Direct | 3/2/2026 | S · Sale | −11.00 | $785.48 | $8.64K | 0.1% | 17.76K | 17.75K |
| Common Stock Direct | 3/2/2026 | S · Sale | −7.00 | $786.61 | $5.51K | 0.0% | 17.75K | 17.75K |
| Common Stock Direct | 3/2/2026 | S · Sale | −2.00 | $787.34 | $1.57K | 0.0% | 17.75K | 17.74K |
| Common Stock Direct | 3/2/2026 | S · Sale | −20.00 | $788.96 | $15.78K | 0.1% | 17.74K | 17.72K |
| Common Stock Direct | 3/2/2026 | S · Sale | −20.00 | $789.28 | $15.79K | 0.1% | 17.72K | 17.70K |
| Total | −100.00 | -$78.55K | ||||||